Clinical Trial Update: Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carfilzomib in patients with multiple myeloma in first relapse or refractory to first-line therapy; the study was terminated but result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Kyprolis (carfilzomib)

Snippet

Sponsor: Attaya Suvannasankha | Conditions: Refractory Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2016-11-02